2024/08/16 15:58:50 | |
---|---|
Price | |
0.55 USD | |
Difference | -6.02% (-0.04) |
ISIN | US90137F3010 |
Symbol | XXII |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 0.5403 USD (700) |
Ask (Ask size) | 0.5499 USD (100) |
Open | 0.58 USD |
High | 0.5999 USD |
Low | 0.5407 USD |
Close (prev. day) | 0.5852 USD |
VWAP | 0.570558 USD |
Volume (pcs) | 53,492 |
Trading volume | 30,545.54 |
Number of trades | 174 |
Last size | 1,000 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings | ||
2024/07/03 | Global Strategy 3Q 2024 | ||
2024/06/21 | Global Equity Ratings |
2024/08/16 15:58:50 | |
---|---|
Price | |
0.55 USD | |
Difference | -6.02% (-0.04) |
ISIN | US90137F3010 |
Symbol | XXII |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 0.5403 USD (700) |
Ask (Ask size) | 0.5499 USD (100) |
Open | 0.58 USD |
High | 0.5999 USD |
Low | 0.5407 USD |
Close (prev. day) | 0.5852 USD |
VWAP | 0.570558 USD |
Volume (pcs) | 53,492 |
Trading volume | 30,545.54 |
Number of trades | 174 |
Last size | 1,000 |
6m | 1Y | 3Y | |
Perf (%) | -76.70% | -98.21% | -99.09% |
Perf (abs.) | -1.93 | -32.05 | -63.89 |
Beta | 1.42 | 1.40 | 1.49 |
Volatility | 176.19 | 147.86 | 189.04 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.66 USD (237,890) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.72 USD (163,687) |
Ø price 100 days | Ø volume 100 days (pcs.) | 1.17 USD (1,152,842) |
Ø price 250 days | Ø volume 250 days (pcs.) | 5.33 USD (501,131) |
YTD High | date | 4.31 USD (2024/04/05) |
YTD Low | date | 0.58 USD (2024/06/24) |
52 Weeks High | date | 35.20 USD (2023/08/22) |
52 Weeks Low | date | 0.58 USD (2024/06/24) |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer